摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲基-2,6-二(吗啉-4-基甲基)苯酚 | 140215-97-0

中文名称
4-甲基-2,6-二(吗啉-4-基甲基)苯酚
中文别名
——
英文名称
4-methyl-2,6-bis(morpholinomethyl)phenol
英文别名
2,6-bis(morpholinomethyl)-4-methylphenol;Phenol, 4-methyl-2,6-bis(4-morpholinylmethyl)-;4-methyl-2,6-bis(morpholin-4-ylmethyl)phenol
4-甲基-2,6-二(吗啉-4-基甲基)苯酚化学式
CAS
140215-97-0
化学式
C17H26N2O3
mdl
——
分子量
306.405
InChiKey
NTGYNTJBSPQRCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    248.31 °C
  • 沸点:
    428.5±40.0 °C(Predicted)
  • 密度:
    1.183±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    45.2
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:67efe38935d9ff8d9a11237c72c38794
查看

反应信息

  • 作为反应物:
    描述:
    4-甲基-2,6-二(吗啉-4-基甲基)苯酚 在 (C2H5)3N 作用下, 以 甲醇乙腈 为溶剂, 生成 [Cu2(2,6-bis(morpholinomethyl)-4-methylphenolato)(azido)3(acetonitrile)2]
    参考文献:
    名称:
    二核、四核和多核铜 (II) 配合物:甲苯和苯氧化的活性催化剂
    摘要:
    三种铜 (II) 配合物与双核 N2O 供体配体 [Cu2(L1)(μ2-pz)(CH3COO)2] (1), [Cu4(L1)2(μ4-O)(μ2-CH3COO)2( μ1,1-N3)(N3)] (2) 和 [Cu2(L2)(μ1,1-N3)(μ1,3-N3)2]∞ (3) [pz = pyrazolato, HL1 = 2,6 -双(吗啉甲基)-4-叔丁基苯酚和 HL2 = 2,6-双(吗啉甲基)-4-甲基苯酚] 已合成并通过元素分析、FTIR 和紫外/可见光谱以及 X 射线晶体学表征。X 射线晶体学研究表明,通过改变桥配体、抗衡阴离子和反应条件,可以形成一系列双核、四核和多核配合物。这些对甲苯和苯的过氧化氢氧化显示出有效的催化性能。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)
    DOI:
    10.1002/ejic.200800556
  • 作为产物:
    描述:
    吗啉聚合甲醛对甲酚1,4-二氧六环 为溶剂, 反应 2.0h, 以26%的产率得到4-甲基-2,6-二(吗啉-4-基甲基)苯酚
    参考文献:
    名称:
    From Tetranuclear 4-Oxo to 4-Peroxocopper(II) Complexes
    摘要:
    The mu(4)-peroxotetracopper(II) complexes [Cu-4(L-1)(2)(O-2)(OMe)(2)(ClO4)]-ClO4 . MeOH (I), [Cu-4(L-2)(2)(O-2)-(OMe)(2)(ClO4)]ClO4 . MeOH (2), [Cu-4-(L-3)(2)(O-2) (OMe)(2)(ClO4)]ClO4 . MeOH (3) and the mu(4)-oxotetracopper(II) complex [Cu-4(L-1)(2)(O)(OH)(2)(MeOH)(2)-(ClO4)(2)] (4) were synthesized (HL1= 2,6-bis(pyrrolidinomethyl)-4-methylphenol, HL2=2,6-bis(piperidinomethyl)4-methylphenol, HL3=2,6-bis(morpholinomethyl)-4-methylphenol). The molecular structures of 1 and 4 were established by single-crystal X-ray crystallography. I crystallizes in the monoclinic space group P2/n, with a=14.797(8), b=11.007(7), c= 15.434(10) Angstrom, beta=118.29 degrees, V=2214 Angstrom(3) (150 K) and Z=2. Complex 4 crystallizes in the monoclinic space group P2(1)/n, with a=11.498(2), b=13.311(3), c= 14.794(3) Angstrom, beta = 93.56(3)degrees, V = 2259.9 Angstrom(3) (213 K) and Z=2. Electrospray ionization mass spectra of 1 and 4 in dichloromethane solution confirm that the tetranuclear structure is maintained in this solvent. The UV/Vis spectra of 1-3 in dichloromethane are dominated by a very strong absorption at about 390 nm with a shoulder around 420-440nm interpreted as a superposition of a peroxo-->Cu-II and a phenolate-->Cu-II charge-transfer transition. A band at about 580 nm may be a superposition of d-d transitions and a second, less intense peroxo-->Cu-II charge transfer. The frequencies of the O-O stretching vibrations of 1-3 were determined by FT Raman and resonance Raman experiments and found to be 878, 898 and 888 cm(-1), respectively. A frequency shift to 841 cm(-1) is observed upon O-18 substitution in 1. The tetranuclear copper(Ir) complexes 1 and 4 are strongly antiferromagnetically coupled. They possess S=0 ground states separated from a triplet state by 510 and 720 cm-l, respectively. Good fits result from a regular spin Hamiltonian as well as from the Bleaney-Bowers equation, which shows that only the two lowest-lying states are notably thermally populated. Magnetostructural correlations established for dimeric complexes are not easily transferable to these kinds of tetrameric complexes. Investigations in methanolic solution provide evidence that a tetranuclear mu(4)-oxocopper(II) complex analogous to 4 can be converted into a tetranuclear mu(4)-peroxocopper-(II) complex analogous to 1.
    DOI:
    10.1002/(sici)1521-3765(19980210)4:2<289::aid-chem289>3.3.co;2-u
点击查看最新优质反应信息

文献信息

  • Teipel, Stephan; Griesar, Klaus; Haase, Wolfgang, Inorganic Chemistry, 1994, vol. 33, # 3, p. 456 - 464
    作者:Teipel, Stephan、Griesar, Klaus、Haase, Wolfgang、Krebs, Bernt
    DOI:——
    日期:——
  • Synthesis and structural characterization of 2,6-bis-(N-methylenemorpholino)-4-methylphenol (MMP) and 2,6-bis-(N-methylenemorpholino)-4-bromophenol (MBrP)
    作者:S. Shanmuga Sundara Raj、M. N. Ponnuswamy、G. Shanmugam、M. Kandaswamy
    DOI:10.1007/bf01665351
    日期:1994.1
    MMP: C17H26N2O3, M(r) = 306.40, monoclinic, space group P2(1)/c, a = 10.927(2), b = 10.777(2), c = 14.197(2)angstrom, beta = 94.04(2)degrees, V = 1667.7(5)angstrom3, D(cal) = 1.22 mgm-3, Z = 4, F(000) = 664, mu = 5.93 cm-1, T = 293K. Final R = 0.049 and wR = 0.063 for 2724 observed reflections. MBrP; C16H23N2O3Br, M(r) = 371.27, monoclinic, space group P2(1)/c, a = 10.955(1), b = 10.785(1), c = 14.213(1)angstrom, beta = 94.54(2)degrees, V = 1674.0(4)angstrom3, D(cal) = 1.48 Mgm-3, Z = 4, F(000) = 768, mu = 32.35 cm-1, T = 293K. Final R = 0.055 and wR = 0.069 for 2886 observed reflections. MMP and MBrP are isostructural and in both the molecules the morpholino rings assume a chair conformation.
  • Uhlenbrock, Stefan; Wegner, Rainer; Krebs, Bernt, Journal of the Chemical Society, Dalton Transactions, 1996, # 18, p. 3731 - 3736
    作者:Uhlenbrock, Stefan、Wegner, Rainer、Krebs, Bernt
    DOI:——
    日期:——
  • US3935160A
    申请人:——
    公开号:US3935160A
    公开(公告)日:1976-01-27
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫